OESOPHAGEAL MONILIASIS IN MALIGNANT NEOPLASTIC DISEASE.
D000666:Amphotericin B; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002177:Candidiasis; D004358:Drug Therapy; D004945:Esophagoscopy; D004947:Esophagus; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009101:Multiple Myeloma; D009369:Neoplasms / Q000532:radiotherapy*; D012509:Sarcoma
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000666:Amphotericin B
AMPHOTERICIN B; ANTIBIOTICS; ANTINEOPLASTIC AGENTS; DRUG THERAPY; ESOPHAGOSCOPY; ESOPHAGUS; HODGKIN'S DISEASE; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; MONILIASIS; MULTIPLE MYELOMA; NEOPLASM RADIOTHERAPY; SARCOMA, RETICULUM CELL